STOCK TITAN

HCA Healthcare (HCA) Financials

HCA NYSE
Trailing 12 months to September 30, 2026
Revenue $78.7B +5.8% YoY
Net Income $6.8B +6.8% YoY
EPS (Diluted) $30.14 +16.5% YoY
Free Cash Flow $6.0B -26.2% YoY
Market Cap $106.9B as of Nov 16, 2026
Price / Sales 1.4x on $78.7B revenue, trailing 12 months to September 30, 2026
Price / Earnings 15.8x on $6.8B net income, trailing 12 months to September 30, 2026
Price / Book n/m negative shareholder equity, so no book multiple, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 16, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q3 FY2026, filed Oct 29, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the HCA SEC filings page.

HCA Healthcare, Inc. (HCA) reported $78.7B in revenue over the twelve months to Sep 30, 2026, up 5.8% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI HCA FY2025

HCA converts earnings into cash efficiently, but its 2025 expansion coincided with a more liability-heavy balance sheet and thinner short-term cushion.

From FY2024 to FY2025, operating cash flow grew 20.2% while net income grew 17.8%, showing cash generation improved at least as quickly as reported profit. Free cash flow then grew 36.4% while capital expenditures grew only 1.4%, pointing to improved cash conversion alongside relatively restrained reinvestment.

Liabilities reached 109.9% of assets and total equity was negative $6.0B in FY2025, making the capital structure liability-funded rather than equity-funded. The current ratio was just below 1.0x while long-term debt rose 8.5%, leaving less short-term flexibility despite operating cash generation.

From FY2023 to FY2025, revenue grew 16.4% while free cash flow grew 64.1%, indicating cash generation scaled faster than reported sales. Capital expenditures grew only 4.2% over the same span, so the improvement was not simply purchased through proportionately heavier reinvestment; buybacks alone reached $10.1B in FY2025.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 61 / 100
Financial Health Score (5 of 6 dimensions) 61/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed: here 5 of 6, with the others left out rather than counted as zero. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of HCA Healthcare, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
77

Profitability ranks operating companies on their operating margin with gains on asset sales taken out, averaged over the last three fiscal years with the newest counting most, and in smaller part on how steady that margin has been. HCA Healthcare, Inc. scores 77/100 on it among other operating companies.

Growth
58

Growth ranks operating companies on the yearly rate at which revenue compounded across the last three fiscal years (the last two where the earliest reports no revenue), counted in the currency each company reports in so that a move in the exchange rate is not read as growth. HCA Healthcare, Inc. scores 58/100 on it among other operating companies.

Leverage
n/a

Not available for HCA Healthcare, Inc., so it is left out of the overall score, which averages the 5 of 6 dimensions that can be computed.

Liquidity
18

HCA Healthcare, Inc. held $0.97 of current assets for every $1 of current liabilities at the end of fiscal year 2025, a current ratio of 0.97. Liquidity ranks operating companies on that ratio, and HCA Healthcare, Inc. scores 18/100 among other operating companies.

Cash Flow
62

Cash Flow ranks operating companies on their free cash flow margin, which is operating cash flow less capital spending as a share of revenue, averaged over the last three fiscal years with the newest weighted most. HCA Healthcare, Inc. scores 62/100 on it among other operating companies.

Returns
92

Returns ranks operating companies on their return on capital employed, which is operating income against total assets less current liabilities, averaged over three fiscal years with the newest weighted most, and in smaller part on how steady that return has been. HCA Healthcare, Inc. scores 92/100 on it among other operating companies.

Piotroski F-Score Partial
6/8

HCA Healthcare, Inc. passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 3 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) passes.

Earnings Quality Cash-Backed
1.86x

For every $1 of reported earnings, HCA Healthcare, Inc. generates $1.86 in operating cash flow ($12.6B OCF vs $6.8B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$19.8B
YoY+3.6%
QoQ-1.9%
5Y CAGR+5.4%

HCA Healthcare, Inc. generated $19.8B in revenue in Q3 2026. This represents an increase of 3.6% from the same quarter a year earlier. Against the prior quarter it is down 1.9%.

Net Income
$1.6B
YoY-3.9%
QoQ-7.1%
5Y CAGR-7.0%
10Y CAGR+9.8%

HCA Healthcare, Inc. reported $1.6B in net income in Q3 2026. This represents a decrease of 3.9% from the same quarter a year earlier. Against the prior quarter it is down 7.1%.

EPS (Diluted)
$7.27
YoY+4.5%
QoQ-4.6%
5Y CAGR+0.8%

HCA Healthcare, Inc. earned $7.27 per diluted share (EPS) in Q3 2026. This represents an increase of 4.5% from the same quarter a year earlier. Against the prior quarter it is down 4.6%.

EBITDA

Not reported for Q3 2026.

Cash & Balance Sheet

Free Cash Flow
$3.1B
YoY-0.8%
QoQ+181.2%
5Y CAGR+17.5%
10Y CAGR+20.2%

HCA Healthcare, Inc. generated $3.1B in free cash flow in Q3 2026, representing cash available after capex. This represents a decrease of 0.8% from the same quarter a year earlier. Against the prior quarter it is up 181.2%.

Cash & Debt
$908.0M
YoY-8.9%
QoQ-10.4%
5Y CAGR-2.4%
10Y CAGR+3.0%

HCA Healthcare, Inc. held $908.0M in cash against $42.4B in long-term debt as of Q3 2026.

Dividends Per Share
$0.78
YoY+8.3%
QoQ0.0%
5Y CAGR+10.2%

HCA Healthcare, Inc. paid $0.78 per share in dividends in Q3 2026. This represents an increase of 8.3% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding
209M
YoY-8.5%
QoQ-3.5%
5Y CAGR-7.7%
10Y CAGR-5.7%

HCA Healthcare, Inc. had 209M shares outstanding in Q3 2026. This represents a decrease of 8.5% from the same quarter a year earlier. Against the prior quarter it is down 3.5%.

Margins & Returns

Net Margin
8.0%
YoY-0.6pp
QoQ-0.4pp
5Y change-6.9pp

HCA Healthcare, Inc.'s net profit margin was 8.0% in Q3 2026, showing the share of revenue converted to profit. This is down 0.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.4 percentage points.

Gross Margin

Not reported for Q3 2026.

Operating Margin

Not reported for Q3 2026.

Return on Equity

Not reported for Q3 2026.

Capital Allocation

Share Buybacks
$3.0B
YoY+18.9%
QoQ+43.9%
5Y CAGR+5.0%
10Y CAGR+23.7%

HCA Healthcare, Inc. spent $3.0B on share buybacks in Q3 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 18.9% from the same quarter a year earlier. Against the prior quarter it is up 43.9%.

Capital Expenditures
$1.4B
YoY+5.4%
QoQ+10.2%
5Y CAGR+8.8%
10Y CAGR+6.7%

HCA Healthcare, Inc. invested $1.4B in capex in Q3 2026, funding long-term assets and infrastructure. This represents an increase of 5.4% from the same quarter a year earlier. Against the prior quarter it is up 10.2%.

R&D Spending

Not reported for Q3 2026.

HCA Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HCA quarterly income statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Revenue$19.8B+3.6%$20.2B+8.7%$19.1B+4.3%$19.5B+6.7%$19.2B+9.6%$18.6B+6.4%$18.3B+5.7%$18.3B+5.7%
SG&A Expenses$146.0M+5.0%$148.0M+13.8%$133.0M+5.6%$153.0M+27.5%$139.0M+25.2%$130.0M+30.0%$126.0M+40.0%$120.0M+20.0%
Interest Expense$607.0M+8.2%$599.0M+5.5%$584.0M+6.8%$572.0M+8.3%$561.0M+8.9%$568.0M+12.3%$547.0M+6.8%$528.0M+7.5%
Income Tax$521.0M+1.2%$564.0M+7.6%$430.0M-14.3%$509.0M+13.9%$515.0M+21.5%$524.0M-4.7%$502.0M+12.8%$447.0M-7.6%
Net Income$1.6B-3.9%$1.7B+2.8%$1.6B+0.6%$1.9B+30.6%$1.6B+29.4%$1.7B+13.1%$1.6B+1.2%$1.4B-10.5%
EPS (Basic)$7.36+4.4%$7.70+11.4%$7.25+11.2%$8.23+44.4%$7.05+42.7%$6.91+23.4%$6.52+8.5%$5.70-4.8%
EPS (Diluted)$7.27+4.5%$7.62+11.6%$7.15+10.9%$8.10+43.9%$6.96+42.6%$6.83+23.5%$6.45+8.8%$5.63-4.6%
Diluted Shares (Avg)217M-8.0%223M-7.9%227M-9.1%N/A236M-9.1%242M-8.4%249M-6.9%N/A

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA.

HCA Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HCA quarterly balance sheet
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Total Assets$63.5B+6.2%$63.3B+6.2%$61.5B+2.8%$60.7B+2.0%$59.7B+0.5%$59.5B+3.8%$59.8B+5.0%$59.5B+5.9%
Current Assets$16.2B+6.1%$17.2B+10.5%$16.1B-1.3%$15.8B-3.8%$15.3B-8.3%$15.6B+2.6%$16.3B+6.4%$16.4B+10.0%
Cash & Equivalents$908.0M-8.9%$1.0B+7.9%$940.0M-11.3%$1.0B-46.2%$997.0M-65.5%$939.0M+13.0%$1.1B-17.4%$1.9B+106.7%
Short-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Inventory$1.7B-3.7%$1.7B-7.3%$1.7B-6.3%$1.7B-4.9%$1.7B-2.4%$1.8B-0.4%$1.8B-5.7%$1.7B-14.0%
Accounts Receivable$11.5B+10.4%$12.3B+17.4%$11.3B+2.1%$10.9B+1.1%$10.4B+5.2%$10.5B+2.1%$11.1B+10.4%$10.8B+8.0%
Long-Term Investments$463.0M-19.2%$402.0M-24.3%$387.0M-29.6%$485.0M-14.8%$573.0M+3.6%$531.0M+9.9%$550.0M+16.8%$569.0M+19.3%
Total Liabilities$71.5B+9.9%$69.9B+9.3%$67.8B+7.0%$66.7B+7.6%$65.1B+5.6%$63.9B+8.4%$63.3B+8.1%$62.0B+6.9%
Current Liabilities$19.8B+10.5%$17.3B+8.6%$19.3B+41.3%$16.4B+7.7%$17.9B+20.1%$15.9B+11.5%$13.6B+3.7%$15.2B+19.9%
Non-Current Liabilities$51.8B+9.7%$52.6B+9.6%$48.5B-2.4%$50.4B+7.6%$47.2B+1.0%$48.0B+7.4%$49.7B+9.4%$46.8B+3.3%
Long-Term Debt$42.4B+10.4%$43.5B+10.3%$39.5B-3.8%$41.6B+8.5%$38.4B+0.3%$39.4B+8.5%$41.1B+10.5%$38.3B+3.1%
Total Equity-$8.1Bn/m-$6.6Bn/m-$6.3Bn/m-$6.0Bn/m-$5.3Bn/m-$4.4Bn/m-$3.5Bn/m-$2.5Bn/m
Retained Earnings-$7.7Bn/m-$6.3Bn/m-$6.0Bn/m-$5.7Bn/m-$5.0Bn/m-$4.1Bn/m-$3.2Bn/m-$2.1Bn/m

Not reported in any period shown, so not listed: Goodwill.

HCA Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HCA quarterly cash flow statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Cash Flow$4.5B+1.0%$2.3B-44.5%$2.0B+22.0%$2.4B-7.8%$4.4B+25.6%$4.2B+113.6%$1.7B-33.1%$2.6B-4.3%
Depreciation & Amortization$954.0M+7.3%$944.0M+9.4%$930.0M+8.1%$911.0M+6.4%$889.0M+5.6%$863.0M+5.4%$860.0M+8.2%$856.0M+8.5%
Stock-Based CompensationN/A$171.0M$86.0M-12.2%N/AN/AN/A$98.0M+12.6%N/A
Capital Expenditures$1.4B+5.4%$1.2B+4.7%$1.1B+12.9%$1.5B+15.9%$1.3B+8.1%$1.2B-8.2%$991.0M-11.4%$1.3B+10.9%
Free Cash Flow$3.1B-0.8%$1.1B-63.6%$895.0M+35.6%$870.0M-31.7%$3.1B+34.6%$3.0B+339.7%$660.0M-51.1%$1.3B-15.9%
Investing Cash Flow-$1.9Bn/m-$1.6Bn/m-$1.3Bn/m-$1.3Bn/m-$1.4Bn/m-$1.3Bn/m-$1.0Bn/m-$1.3Bn/m
Financing Cash Flow-$2.6Bn/m-$704.0Mn/m-$830.0Mn/m-$999.0Mn/m-$3.0Bn/m-$3.1Bn/m-$1.5Bn/m-$2.2Bn/m
Dividends Paid$165.0M-0.6%$171.0M0.0%$183.0M+1.7%$162.0M-1.8%$166.0M-1.8%$171.0M0.0%$180.0M-2.7%$165.0M+3.1%
Share Buybacks$3.0B+18.9%$2.1B-17.6%$1.6B-37.3%$2.6B+50.5%$2.5B+39.2%$2.5B+83.2%$2.5B+112.4%$1.7B+86.8%

HCA Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HCA quarterly financial ratios
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Net Margin8.0%-0.6pp8.4%-0.5pp8.5%-0.3pp9.6%+1.8pp8.6%+1.3pp8.9%+0.5pp8.8%-0.4pp7.9%-1.4pp
Return on Assets2.5%-0.3pp2.7%-0.1pp2.6%-0.1pp3.1%+0.7pp2.8%+0.6pp2.8%+0.2pp2.7%-0.1pp2.4%-0.4pp
Current Ratio0.820.0x0.990.0x0.83-0.4x0.97-0.1x0.85-0.3x0.98-0.1x1.190.0x1.08-0.1x
Asset Turnover0.310.0x0.320.0x0.310.0x0.320.0x0.320.0x0.310.0x0.310.0x0.310.0x
FCF Margin15.6%-0.7pp5.5%-10.8pp4.7%+1.1pp4.5%-2.5pp16.3%+3.0pp16.3%+12.4pp3.6%-4.2pp7.0%-1.8pp

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Return on Equity, Debt-to-Equity, Liabilities-to-Equity.

Note: Shareholder equity is negative (-$6.0B), which causes the debt-to-equity, liabilities-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.97), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
HCA Healthcare, Inc. HCA FY2025 $75.6B $6.8B 9.0% $106.9B 61/100
Tenet Healthcare Corporation New THC FY2025 $21.3B $1.4B 6.6% $23.2B 55/100
Universal Health Services, Inc. UHS FY2025 $17.4B $1.5B 8.6% $11.4B 53/100
DaVita Inc. DVA FY2025 $13.6B $746.8M 5.5% $11.0B 55/100
Encompass Health Corporation EHC FY2025 $5.9B $566.2M 9.5% $13.9B 59/100
Fresenius Medical Care AG FMS FY2025 $23.0B $1.1B 5.0% $12.2B 47/100

Frequently Asked Questions

HCA Healthcare, Inc. (HCA) reported $75.6B in total revenue for fiscal year 2025. This represents a 7.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

HCA Healthcare, Inc. (HCA) revenue grew by 7.1% year-over-year, from $70.6B to $75.6B in fiscal year 2025.

Yes, HCA Healthcare, Inc. (HCA) reported a net income of $6.8B over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net income of $6.8B, with a net profit margin of 9.0%.

HCA Healthcare, Inc. (HCA) reported diluted earnings per share of $28.33 for fiscal year 2025. This represents a 28.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

As of fiscal year 2025, HCA Healthcare, Inc. (HCA) had $1.0B in cash and equivalents against $41.6B in long-term debt.

HCA Healthcare, Inc. (HCA) had a net profit margin of 9.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, HCA Healthcare, Inc. (HCA) paid $2.88 per share in dividends during fiscal year 2025.

HCA Healthcare, Inc. (HCA) generated $7.7B in free cash flow during fiscal year 2025. This represents a 36.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

HCA Healthcare, Inc. (HCA) generated $12.6B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

HCA Healthcare, Inc. (HCA) had $60.7B in total assets as of fiscal year 2025, including both current and long-term assets.

HCA Healthcare, Inc. (HCA) invested $4.9B in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, HCA Healthcare, Inc. (HCA) spent $10.1B on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

HCA Healthcare, Inc. (HCA) had 224M shares outstanding as of fiscal year 2025.

HCA Healthcare, Inc. (HCA) had a current ratio of 0.97 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

HCA Healthcare, Inc. (HCA) had a return on assets of 11.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

HCA Healthcare, Inc. (HCA) trades at 15.8x earnings, its market capitalization divided by $6.8B net income, trailing 12 months to September 30, 2026. The market capitalization is $106.9B as of Nov 16, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

HCA Healthcare, Inc. (HCA) trades at 1.4x sales, its market capitalization divided by $78.7B revenue, trailing 12 months to September 30, 2026. The market capitalization is $106.9B as of Nov 16, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

HCA Healthcare, Inc. (HCA) has negative shareholder equity of -$6.0B as of fiscal year 2025, so no debt-to-equity or liabilities-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

HCA Healthcare, Inc. (HCA) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

HCA Healthcare, Inc. (HCA) has an earnings quality ratio of 1.86x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

HCA Healthcare, Inc. (HCA) scores 61 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. For HCA Healthcare, Inc. it averages the 5 of 6 dimensions that can be computed; the others are left out rather than counted as zero. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top